Wyniki wyszukiwania:

The Supplementary Protection Certificate (SPC) prolongs the term of patents for pharmaceutical products for a maximum of five additional years. The legal bases are two European SPC Regulations, and the SPC is based upon European or national patents. SPCs protect some of the most valuable products in the pharmaceutical industry, where each day of additional protection may be worth millions of euros. Despite the economic relevance SPCs have obtained in recent years, there exists only limited detailed literature on the subject. German jurisprudence on SPCs is of special importance, as this has...

This commentary offers the definitive guide to supplementary protection certificates (SPC); a key element in the regulation of the pharmaceutical and medical market within Europe. Beyond providing an overview of the European legislation and the CJEU case-law on SPCs, it also depicts and summarises national law and jurisprudence on leading pharmaceutical markets such as Germany, France and the United Kingdom as well as The Netherlands, Italy and Switzerland. Patent lawyers, those practising in the medical and pharmaceutical field as well as judges and academics will find this an invaluable...